Skip to content
Use caution Drug recall · FDA · Published February 2, 2016

Isomeric Pharmacy Recalls Triamcinolone Vials Due to Labeling Errors

Isomeric Pharmacy recalls 114 vials of Triamcinolone Diacetate Injectable Suspension due to incorrect or missing lot and expiration dates on labels.

🇺🇸 FDA recall #D-0728-2016DrugIsomeric Pharmacy ›
Take action

Contact the company

Recalling firmIsomeric Pharmacy Solution, LLC2401 S Foothill Dr · Salt Lake City, UT 84109-1479
✎ GovInfoNow plain-language explainer

What happened, in plain English

Isomeric Pharmacy Solution, LLC is recalling a small batch of Triamcinolone Diacetate Injectable Suspension because the labeling may contain incorrect or missing information. Specifically, some vials might have wrong compounded dates, lot numbers, or 'Do Not Use Beyond' dates that are longer than intended. This recall affects 114 vials distributed nationwide. Read more at govinfonow.com/recall/43202-isomeric-pharmacy-recalls-triamcinolone-vials-due-to-labeling-errors.

Source Summary by GovInfoNow · govinfonow.com/recall/43202-isomeric-pharmacy-recalls-triamcinolone-vials-due-to-labeling-errors · Updated October 11, 2026 · FDA enforcement record: FDA #D-0728-2016

Cite this page

“Isomeric Pharmacy Recalls Triamcinolone Vials Due to Labeling Errors.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43202-isomeric-pharmacy-recalls-triamcinolone-vials-due-to-labeling-errors. Based on FDA recall #D-0728-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0728-2016%22&limit=1).

Why it’s dangerous

The primary hazard is labeling errors that could lead to the use of medication past its intended safety date. If the 'Do Not Use Beyond' date is incorrect or missing, there is a risk that the compounded drug is used when it may no longer be sterile or effective.

Who’s affected

Patients who received Triamcinolone Diacetate Injectable Suspension from Isomeric Pharmacy Solution, LLC between December 2015 and March 2016. Healthcare providers or patients holding the specific lot number listed in the record are most at risk.

How to tell if you have this one

Check for Triamcinolone Diacetate Injectable Suspension, 40 mg/mL, 10mL Multi-Dose Vial for Injection, Rx only, manufactured by Isomeric Pharmacy. Look specifically for Lot Number: 12212015@8 and a 'Compounded on' date of December 21, 2015.

  • Brand
    Isomeric Pharmacy
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Vial Label

    Verify if your vial matches Lot Number 12212015@8 and was compounded on December 21, 2015.

  2. Contact Your Provider

    If you have the recalled lot, contact your healthcare provider or pharmacist immediately for guidance on disposal or replacement.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3 months after the firm started it.

1. Firm started the recall: Feb 2, 201612. FDA classified it Class III: Feb 25, 201623. Published in FDA’s Enforcement Report: Mar 2, 201634. FDA terminated the recall: May 3, 201642016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0728-2016 (February 2, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0728-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA